BioCardia, Inc. (BCDA) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts BCDA Hot Sheet
Join SI Premium – FREE
BioCardia, Inc. (NASDAQ: BCDA) reported Q2 EPS of ($0.08), $0.12 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $30 thousand.
For earnings history and earnings-related data on BioCardia, Inc. (BCDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Softbank Said To Weigh Buying Largest Us Security Firm Allied - Bloomberg
- Advasa sets 50% dividend payout target starting fiscal year 2027
- Williams Trading Downgrades Birkenstock Holding plc (BIRK) to Sell, 'Stock Less Comfortable than the Shoes'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
